Author:
Kertesz Stefan G.,Manhapra Ajay,Gordon Adam J.
Abstract
This manuscript describes the institutional and clinical considerations that apply to the question of whether to mandate opioid dose reduction in patients who have received opioids long-term. It describes how a calamitous rise in addiction and overdose involving opioids has both led to a clinical recalibration by healthcare providers, and to strong incentives favoring forcible opioid reduction by policy making agencies. Neither the 2016 Guideline issued by the Centers for Disease Control and Prevention nor clinical evidence can justify or promote such policies as safe or effective.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference69 articles.
1. Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids
2. A crisis of opioids and the limits of prescription control: United States
3. 9. Substance Abuse and Mental Health Services Administration, “Results from the 2014 National Survey on Drug Use and Health: Detailed Tables,” 2015, available at (last visited April 8, 2020).
4. International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering
5. 29. Human Rights Watch, “Not Allowed to Be Compassionate” Chronic Pain, the Overdose Crisis, and Unintended Harms in the US (2018), available at (last visited April 8, 2020).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献